2022. The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients who can Forego Sentinel Lymph Node Biopsy when Applying NCCN Guidelines. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), 474–481. DOI:https://doi.org/10.25251/skin.6.6.4.